Pressurised metered dose inhalers (MDI)

Details Pressurised metered dose inhalers (MDI) Pressurised metered dose inhalers (MDI)

1999-11-23

2008-03-25

Mitchell, Teena (Department: 3771)

Surgery

Liquid medicament atomizer or sprayer

Pre-pressurized container holding medicament

C128S203150

Reexamination Certificate

active

07347199

ABSTRACT:
The invention relates to the use of pressurized metered dose inhalers (MDIs) having part or all of their internal surfaces consisting of stainless steel, anodised aluminum or lined with an inert organic coating; and to compositions to be delivered with said MDIs.

REFERENCES:
patent: 3361306 (1968-01-01), Grim
patent: 3622053 (1971-11-01), Ryden
patent: 4185100 (1980-01-01), Rovee et al.
patent: 4499108 (1985-02-01), Sequeira et al.
patent: 4579854 (1986-04-01), Iwakuma et al.
patent: 4835145 (1989-05-01), MacDonald
patent: 5192528 (1993-03-01), Radhakrishnan et al.
patent: 5415853 (1995-05-01), Hettche et al.
patent: 5435297 (1995-07-01), Klein
patent: 5605674 (1997-02-01), Purewal et al.
patent: 5642728 (1997-07-01), Andersson et al.
patent: 5653961 (1997-08-01), McNally et al.
patent: 5676930 (1997-10-01), Jager et al.
patent: 5683677 (1997-11-01), Purewal et al.
patent: 5695743 (1997-12-01), Purewal et al.
patent: 5891419 (1999-04-01), Cutie
patent: 5954047 (1999-09-01), Armer et al.
patent: 5955058 (1999-09-01), Jager et al.
patent: 6004537 (1999-12-01), Blondino et al.
patent: 6006745 (1999-12-01), Marecki
patent: 6026808 (2000-02-01), Armer et al.
patent: 6045778 (2000-04-01), Jager et al.
patent: 6131566 (2000-10-01), Ashurst et al.
patent: 6143277 (2000-11-01), Ashurst et al.
patent: 6149892 (2000-11-01), Britto
patent: 6150418 (2000-11-01), Hochrainer et al.
patent: 6241969 (2001-06-01), Saidi et al.
patent: 6253762 (2001-07-01), Britto
patent: 6290930 (2001-09-01), Blondino et al.
patent: 6315985 (2001-11-01), Wu et al.
patent: 6413496 (2002-07-01), Goodman et al.
patent: 6451285 (2002-09-01), Blondino et al.
patent: 6645466 (2003-11-01), Keller et al.
patent: 7018618 (2006-03-01), Lewis et al.
patent: 2003/0077230 (2003-04-01), Blondino et al.
patent: 2003/0157028 (2003-08-01), Lewis et al.
patent: 2003/0190267 (2003-10-01), Lewis et al.
patent: 2003/0190287 (2003-10-01), Lewis et al.
patent: 2003/0190289 (2003-10-01), Lewis et al.
patent: 2003/0206870 (2003-11-01), Lewis et al.
patent: 2005/0129621 (2005-06-01), Davies et al.
patent: 2005/0142071 (2005-06-01), Lewis et al.
patent: 2005/0152846 (2005-07-01), Davies et al.
patent: 2005/0154013 (2005-07-01), Davies et al.
patent: 2005/0220718 (2005-10-01), Lewis et al.
patent: 0 372 777 (1990-06-01), None
patent: 0 504 112 (1992-09-01), None
patent: 0 642 992 (1995-03-01), None
patent: 0 653 204 (1995-05-01), None
patent: 0 911 048 (1999-04-01), None
patent: 1 525 181 (1978-09-01), None
patent: 2 326 334 (1998-12-01), None
patent: WO 91/11173 (1991-08-01), None
patent: WO 92/11236 (1992-07-01), None
patent: WO 92/20391 (1992-11-01), None
patent: WO 93/05765 (1993-04-01), None
patent: WO 93/11747 (1993-06-01), None
patent: WO 93/18746 (1993-09-01), None
patent: WO 94/13262 (1994-06-01), None
patent: WO 94/14490 (1994-07-01), None
patent: WO 94/21228 (1994-09-01), None
patent: WO 94/21229 (1994-09-01), None
patent: WO 95/17195 (1995-06-01), None
patent: WO 96/18384 (1996-06-01), None
patent: WO 96/19198 (1996-06-01), None
patent: WO 96/19968 (1996-07-01), None
patent: WO 96/19969 (1996-07-01), None
patent: WO 96/32099 (1996-10-01), None
patent: WO 96/32150 (1996-10-01), None
patent: WO 96/32151 (1996-10-01), None
patent: WO 96/32345 (1996-10-01), None
patent: WO 97/47286 (1997-12-01), None
patent: WO 98/01147 (1998-01-01), None
patent: WO 98/03533 (1998-01-01), None
patent: WO 98/05302 (1998-02-01), None
patent: WO 98/13031 (1998-04-01), None
patent: WO 98/24420 (1998-06-01), None
patent: WO 98/34595 (1998-08-01), None
patent: WO 98/34596 (1998-08-01), None
patent: WO 98/56349 (1998-12-01), None
patent: WO 91/12596 (1999-03-01), None
patent: WO 99/64014 (1999-12-01), None
patent: WO 99/65460 (1999-12-01), None
patent: WO 99/65464 (1999-12-01), None
patent: WO 00/06121 (2000-02-01), None
patent: WO 00/07567 (2000-02-01), None
patent: WO 00/23065 (2000-04-01), None
patent: WO 00/30608 (2000-06-01), None
patent: WO 00/35458 (2000-06-01), None
patent: WO 00/53157 (2000-09-01), None
patent: WO 00/78286 (2000-12-01), None
patent: WO 01/47493 (2001-07-01), None
patent: WO 93/11743 (2003-06-01), None
R.O. Williams, III, et al.,European Journal of Pharmaceutics and Biopharmaceutics, vol. 44, pp. 195-203 (1997).
U.S. Appl. No. 10/766,857, filed Jan. 30, 2004, Lewis et al.
B. Meakin, “Fine Particle Dose Control of Solution Based pMDIs”,Drug Delivery to the Lungs IX, The Aerosol Society, pp. 1-20, (Dec. 14 & 15, 1998).
ABPI Compendium of Data Sheets and Summaries of Product Characteristics, Datapharm Publications Limited, London, pp. 81-82, (1996-1997).
Paul A. Sanders, Ph.D., “Homogeneous Systems and Their Properties”,Handbook of Aerosol Technology, Second Edition, Van Nostrand Reinhold Company, NY, p. 30, 1979.
G. Brambilla et al, “Modulation of Aerosol Clouds Produced by HFA Solution Inhalers”,Portable Inhalers, pp. 1559-159, (Nov. 26 & 27, 1998).
U.S. Appl. No. 09/831,888, filed Jul. 19, 2001, Lewis et al.
S.S. Davis, “Physico-Chemical Studies on Aerosol Solutions For Drug Delievery I. Water-Propylene glycol Systems”,International Journal of Pharmaceutics, 1, 1978, pp. 71-83.
L. Harrison et al, “Twenty-eight-day Double-blind Safety Study of an HFA-134a Inhalation Aerosol System in Healthy Subjects”,J. Pharm. Pharmacol., 1996, vol. 48, pp. 596-600.
P. Hoet et al, “Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons”,The Lancet, 1997, vol. 350, pp. 555-559.
J. Daly, Jr., “Properties and toxicology of CFC alternatives”,Aerosol Age, Feb. 1990, pp. 26-27, 40, 56 and 57.
D. Strobach, “Alternatives to CFCs” Part II,Aerosol Age, Jul. 1988, pp. 32-33, 42 and 43.
Tsi-Zong Tzou et al, “Drug Form Selection in Albuterol-Containing Metered-Dose Inhaler Formulations and Its Impact on Chemical and Physical Stability”,Journal of Pharmaceutical Sciences, 1997, vol. 86, No. 12, pp. 1352-1357.
M.J. Kontny et al, “Issues Surrounding MDI Formulation Development with Non-CFC Propellants”,Journal of Aerosol Medicine, 1991, vol. 4, No. 3, pp. 181-187.
I. P. Tansey, “Changing to CFC-Free Inhalers: The Technical and Clinical Challenges”,The Pharmaceutical Journal, 1997, vol. 259, pp. 896-898.
D. Tiwari et al, Compatibility Evaluation of Metered-Dose Inhaler Valve Elastomers with Tetrafluoroethane (P134a), a Non-CFC Propellant,Drug Development and Industrial Pharmacy, 1998, vol. 24, No. 4, pp. 345-352.
Handbook of Pharmaceutical Excipients, 3rd Ed., Kibbe Editor, pp. 7-9, 220-222, 234-235 and 560-561.
L. I. Harrison et al, “Pharmacokinetics and Dose Proportionality of Beclomethasone From Three Strengths of A CFC-Free Beclomethasone Dipropionate Metered-Dose Inhaler”,Biopharmaceutics&Drug Disposition, 1997, vol. 18, No. 7, pp. 635-643.
Chet Leach, “Enhanced Drug Delivery Through Reformulating MDIs with HFA Propellants-Drug Deposition and Its Effect on Preclinical and Clinical Programs”,Respiratory Drug Delivery V, 1996, pp. 133-144.
U.S. Appl. No. 11/289,479, filed Nov. 30, 2005, Lewis et al.
U.S. Appl. No. 10/531,867, filed Sep. 16, 2005, Church et al.
U.S. Appl. No. 09/147,669, filed Feb. 24, 1999, Lewis et al.
U.S. Appl. No. 10/546,619, filed Aug. 23, 2005, Razzetti et al.

Affiliated with

Also associated with

Rating

Pressurised metered dose inhalers (MDI) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pressurised metered dose inhalers (MDI), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pressurised metered dose inhalers (MDI) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3980257